DOD Ovarian Cancer, Clinical Trial Academy – Early-Career Investigator Award
ID: 358736Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/358736
Timeline
    Description

    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the Ovarian Cancer Clinical Trial Academy – Early-Career Investigator Award for Fiscal Year 2025. This grant aims to support early-career investigators in conducting clinical trials focused on ovarian cancer, emphasizing professional development, intensive mentoring, and networking opportunities. The program is critical for enhancing the research landscape in ovarian cancer, with an estimated total funding of approximately $1.4 million available for a maximum of four years. Interested applicants must submit a pre-application by June 12, 2025, followed by a full application due on September 11, 2025, and can reach out to the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507 for further information.

    Point(s) of Contact
    help@eBRAP.org
    Files
    Title
    Posted
    HT942525OCRPOCCTAECI_GG.pdf
    The Department of Defense's Ovarian Cancer Clinical Trial Academy (OCCTA) is offering the Early-Career Investigator Award for FY25, aimed at supporting emerging scientists in conducting clinical trials related to ovarian cancer. The program is designed to foster professional development, provide intensive mentoring, and facilitate networking among Early-Career Investigators (ECIs). Notably, applicants must be within 12 years of their last postdoctoral position and commit at least 25% of their time to the award activities. The grant, totaling approximately $1.4 million per award for a maximum of four years, requires a two-step application process, starting with a pre-application due on June 12, 2025, followed by a full application due on September 11, 2025. The program promotes translational research and encourages collaborations with experienced clinical trialists serving as designated mentors. Successful proposals must demonstrate access to diverse patient populations, an understanding of statistical methods, and a viable recruitment strategy. The initiative underscores the Defense Health Program's mission to advance research that enhances health outcomes for Service Members, Veterans, and all women impacted by ovarian cancer. By integrating research with career development, the OCCTA aims to equip ECIs with the skills needed for independent careers in cancer research.
    OCRP_FY25.pdf
    The Fiscal Year 2025 (FY25) Department of Defense Ovarian Cancer Research Program (OCRP) offers the Ovarian Cancer Clinical Trial Academy – Early-Career Investigator Award aimed at supporting early-career investigators. Applicants must meet specific eligibility criteria, including being within 12 years of completing their last postdoctoral research position or clinical fellowship by the submission deadline of September 11, 2025. Furthermore, candidates are required to commit at least 25% of their time to the award activities during the first two years. The application includes a certification section for both the Principal Investigator (PI) and an official from the PI’s organization to affirm the eligibility requirements and commitment to the award. This funding opportunity emphasizes supporting emerging researchers in ovarian cancer clinical trials and enhancing the research landscape in this critical area of health.
    Similar Opportunities
    DOD Ovarian Cancer, Investigator-Initiated Research Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the Ovarian Cancer Research Program (OCRP) Investigator-Initiated Research Award for fiscal year 2025. This grant aims to support innovative research that addresses critical needs in ovarian cancer care, with a focus on areas such as ovarian cancer biology, novel therapies, prevention strategies, early detection, and enhancing patient survivorship. The program is significant for advancing ovarian cancer research and improving care for service members and the broader community. Interested applicants can submit a pre-application by June 12, 2025, with full applications due by September 11, 2025. The estimated total program funding is $8,050,000, with individual awards up to $1.05 million for single Principal Investigators and $1.4 million for partnering PIs, and preliminary data is required to demonstrate the scientific validity of the proposed research. For further inquiries, applicants can contact the CDMRP Help Desk at 301-682-5507 or via email at help@eBRAP.org.
    DOD Ovarian Cancer, Pilot Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY25 Ovarian Cancer Research Pilot Award, aimed at fostering innovative research in ovarian cancer. This grant opportunity encourages projects that explore groundbreaking concepts and approaches to enhance early detection and prevention strategies, with a focus on significant advancements that can impact patient care. The total funding available is approximately $3.15 million, with nine awards anticipated, each capped at $350,000 for a maximum duration of two years. Interested applicants must submit a pre-application by June 12, 2025, followed by full applications due by September 11, 2025. For further inquiries, applicants can contact the CDMRP Help Desk at 301-682-5507 or via email at help@eBRAP.org.
    DOD Peer Reviewed Cancer, Clinical Trial Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering a grant opportunity for the fiscal year 2025 under the Peer Reviewed Cancer Research Program (PRCRP) Clinical Trial Award (CTA). This grant aims to support the rapid implementation of clinical trials that have the potential to significantly impact cancer treatment, specifically targeting designated cancer types relevant to military health. The program emphasizes the importance of advancing cancer research to benefit service members, veterans, and their families, with funding available for projects ranging from initial proof-of-concept trials to large-scale phase III trials, capped at a total cost of $4.2 million over a maximum performance period of four years. Interested applicants must submit pre-applications by June 20, 2025, followed by full applications due by September 25, 2025, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DOD Peer Reviewed Cancer, Idea Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the fiscal year 2025 Peer Reviewed Cancer Research Program (PRCRP) Idea Award to support innovative cancer research that prioritizes military health. This grant aims to fund high-risk, high-reward proposals that focus on specific cancer types relevant to Service Members, Veterans, and their families, with an emphasis on introducing new paradigms in cancer care and addressing environmental exposure risks. With an estimated total program funding of approximately $14 million, the program anticipates awarding around 25 projects, each with a maximum funding limit of $560,000 for a duration of up to two years. Interested applicants must submit a pre-application by June 20, 2025, followed by a full application due by September 25, 2025; for further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Rare Cancers, Idea Development Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering a funding opportunity for the Rare Cancers Research Program (RCRP) Idea Development Award for fiscal year 2025. This grant aims to support innovative research that explores new ideas and develops impactful strategies in the area of rare cancers, which are defined as those affecting six or fewer individuals per 100,000 annually in the U.S. Eligible applicants include various organizations, and the program encourages interdisciplinary collaboration among military, academic, and industry sectors to enhance health outcomes for military Service Members, Veterans, and the broader public. The total estimated program funding is $6,860,000, with a funding limit of $490,000 per application. Key deadlines include a pre-application due by July 1, 2025, and a full application by October 6, 2025. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.
    DOD Peer Reviewed Cancer, Career Development Award – Scholar Option
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the Peer Reviewed Cancer Research Program (PRCRP) Career Development Award – Scholar Option (CDA-SO) for fiscal year 2025. This grant aims to support independent early-career investigators, referred to as Scholars, in conducting impactful cancer research under the mentorship of an experienced Career Guide, with a focus on military health-related cancer issues. The program has an estimated total funding of approximately $9.9 million, with about nine awards anticipated, each capped at $1.1 million. Interested applicants must submit a pre-application by June 19, 2025, followed by a full application due by July 3, 2025. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Peer Reviewed Medical Research Program, Clinical Trial Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering a grant opportunity under the Peer Reviewed Medical Research Program (PRMRP) for the fiscal year 2025, specifically for the Clinical Trial Award (CTA). This program aims to support the rapid implementation of clinical trials that can significantly impact the treatment or management of diseases relevant to military health, with a focus on areas such as autoimmune disorders, cardiovascular health, infectious diseases, and neuroscience. Approximately $32 million is available for this initiative, with an expected four awards, each capped at $8 million, and applications are due by July 21, 2025. Interested applicants can reach out to the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507 for further assistance.
    DoD Prostate Cancer, Clinical Consortium Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the Fiscal Year 2025 Prostate Cancer Research Program Clinical Consortium Award, aimed at advancing clinical trials for novel therapeutic interventions in prostate cancer. This grant supports the establishment of a consortium of leading researchers across multiple institutions to expedite the clinical advancement of treatments, with a focus on understanding disease progression, improving patient quality of life, and ensuring equitable access to care for high-risk populations. The total estimated funding for this opportunity is approximately $36.8 million, with $12.2 million allocated for one Coordinating Center and $24.6 million for up to eleven clinical research sites, each with specific funding caps and a duration of four years. Interested applicants must submit a pre-application by August 8, 2025, followed by a full application by August 29, 2025; for further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Rare Cancers, Resource and Community Development Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY25 Rare Cancers Research Program Resource and Community Development Award, with an estimated total funding of $5.6 million aimed at enhancing research resources and clinical data related to rare cancers. This grant seeks to address critical gaps in rare cancer research, including the lack of resources, communication strategies, and data-sharing infrastructure, while emphasizing the integration of patient advocates throughout the project lifecycle. Eligible applicants include both domestic and foreign non-profit and for-profit organizations, with applications due by October 6, 2025, following a pre-application deadline of July 1, 2025. For further inquiries, interested parties can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.
    DoD Breast Cancer Clinical Research Extension Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the Breast Cancer Clinical Research Extension Award as part of the Fiscal Year 2025 Breast Cancer Research Program (BCRP). This grant aims to enhance the impact of breast cancer clinical studies by extending data collection, follow-up, and analysis, specifically addressing challenges such as early trial termination and limited patient follow-up. Approximately $26.35 million is available to fund around three projects, with direct cost caps of $5 million for single Principal Investigators (PIs) and $6 million for partnered PIs, requiring the involvement of at least two breast cancer consumer advocates in the research team. Interested applicants must submit a pre-application by June 13, 2025, followed by a full application due by June 27, 2025, with successful proposals notified within six weeks post-review. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.